MGST2
Microsomal glutathione S-transferase 2
Also known as: MGST-II, MGST2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99735
- Gene
- MGST2
- Ensembl
- ENSG00000085871
- Chromosome
- 4
- Canonical length
- 147 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Cytosol
- Quaternary structure
- Homotrimer
OverviewNCBI Gene
The MAPEG (Membrane Associated Proteins in Eicosanoid and Glutathione metabolism) family consists of six human proteins, several of which are involved in the production of leukotrienes and prostaglandin E, important mediators of inflammation. This gene encodes a protein which catalyzes the conjugation of leukotriene A4 and reduced glutathione to produce leukotriene C4. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
147 residues, UniProt reviewed canonical sequence.
>Q99735|MGST2
1 MAGNSILLAA VSILSACQQS YFALQVGKAR LKYKVTPPAV TGSPEFERVF RAQQNCVEFY
61 PIFIITLWMA GWYFNQVFAT CLGLVYIYGR HLYFWGYSEA AKKRITGFRL SLGILALLTL
121 LGALGIANSF LDEYLDLNIA KKLRRQFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MGST2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 367 nTPM
Expression across tissuesHPA
Tissue
- liver: 367 nTPM
- esophagus: 184 nTPM
- small intestine: 135 nTPM
- duodenum: 125 nTPM
- rectum: 114 nTPM
- heart muscle: 112 nTPM
Single-cell type
- esophageal apical cells: 1,055 nCPM
- esophageal suprabasal cells: 848 nCPM
- gastric progenitor cells: 775 nCPM
- hofbauer cells: 692 nCPM
- hepatocytes: 513 nCPM
- breast lactating cells: 491 nCPM
Immune cell
- plasmacytoid DC: 195 nTPM
- myeloid DC: 147 nTPM
- classical monocyte: 104 nTPM
- intermediate monocyte: 65 nTPM
- basophil: 44 nTPM
- total PBMC: 40 nTPM
Brain region
- choroid plexus: 39 nTPM
- white matter: 27 nTPM
- medulla oblongata: 22 nTPM
- spinal cord: 22 nTPM
- pons: 21 nTPM
- hypothalamus: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MGST2.
Disease | ImmuneIEDB
Conditions an epitope on MGST2 was assayed in.
- influenza T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.93
- gnomAD pLI
- 0.08
- gnomAD missense Z
- 0.37
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- glutathione biosynthetic process
- leukotriene biosynthetic process
- lipid metabolic process
- membrane lipid catabolic process
- positive regulation of inflammatory response
- response to lipopolysaccharide
Molecular functions
- enzyme activator activity
- glutathione binding
- glutathione peroxidase activity
- glutathione transferase activity
- identical protein binding
- leukotriene-C4 synthase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MGST2 as an antibody target. Whether an autoantibody or antibody against MGST2 could matter depends on whether native MGST2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MGST2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MGST2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...